Prognostic factors of disease-free survival after thyroidectomy in 170 young patients with a RET germline mutation: A multicenter study of the Groupe Français d'Etude des Tumeurs Endocrines

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 3, 2011, Pages

  Rohmer, Vincent ^a,b   Vidal Trecan, G ^c   Bourdelot, A ^a   Niccoli, P ^d   Murat, A ^e   Wemeau, J L ^f   Borson Chazot, F ^g   Schvartz, C ^h   Tabarin, A ⁱ   Chabre, O ^j   Chabrier, G ^k   Caron, P ^l   Rodien, P ^a,b   Schlumberger, M ^m   Baudin, E ^m  

^a ANGERS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ D'ANGERS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g UNIVERSITÉ LYON 1   (France)

^h Centre de Lutte Contre le Cancer   (France)

ⁱ HAUT LÉVÊQUE HOSPITAL   (France)

^j GRENOBLE UNIVERSITY HOSPITAL   (France)

^k UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^l TOULOUSE UNIVERSITY HOSPITAL   (France)

^m INSTITUT GUSTAVE ROUSSY   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; PENTAGASTRIN; PROTEIN RET;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER STAGING; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DYSPHONIA; FAMILIAL CANCER; FEMALE; FOLLOW UP; GENE IDENTIFICATION; GENE MUTATION; GENOTYPE; HUMAN; HYPOPARATHYROIDISM; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RECURRENT LARYNGEAL NERVE PALSY; RETROSPECTIVE STUDY; SCHOOL CHILD; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TUMOR VOLUME;

ADOLESCENT; ADULT; CALCITONIN; CARCINOMA, MEDULLARY; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; DNA; FEMALE; GENOTYPE; GUIDELINES AS TOPIC; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; MICRONUCLEUS, GERMLINE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MUTATION; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-RET; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952292850     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1234     Document Type: Article

References (32)

1. Pelizzo MR, Boschin IM, Bernante P, Toniato A, Piotto A, Pagetta C, Nibale O, Rampin L, Muzzio PC, Rubello D 2007 Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients. Eur J Surg Oncol 33:493-497 (Pubitemid 46586095)
2. Leboulleux S, Baudin E, Travagli JP, Schlumberger M 2004 Medullary thyroid carcinoma. Clin Endocrinol (Oxf) 61:299-310 (Pubitemid 39287058)
3. Wells Jr SA, Franz C 2000 Medullary carcinoma of the thyroid gland. World J Surg 24:952-956 (Pubitemid 30461216)
4. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells Jr SA, Marx SJ 2001 Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86:5658-5671 (Pubitemid 33152604)
5. Kloos RT, Eng C, Evans DB, Francis GL, Gagel RF, Gharib H, Moley JF, Pacini F, Ringel MD, Schlumberger M, Wells Jr SA 2009 Medullary thyroid cancer: management guidelines of the American Thyroid Association. Thyroid 19:565-612
6. Machens A, Lorenz K, Dralle H 2009 Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels. Ann Surg 250:305-310
7. Niccoli-Sire P, Murat A, Rohmer V, Gibelin H, Chabrier G, Conte-Devolx B, Visset J, Ronceray J, Jaeck D, Henry JF, Proye C, Carnaille B, Kraimps JL 2003 When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations? Surgery 134:1029-1036; discussion 1036-1027
8. Scollo C, Baudin E, Travagli JP, Caillou B, Bellon N, Leboulleux S, Schlumberger M 2003 Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. J Clin Endocrinol Metab 88:2070-2075 (Pubitemid 36549878)
9. Franck-Raue KH, W Buhr, H Herfarth, C Ziegler, R Raue, F 1996 Application of genetic screening in families with hereditary medullary thyroid carcinoma. Exp Clin Endocrinol Diabetes 104(Suppl 4):108-110
10. Frilling A, Dralle H, Eng C, Raue F, Broelsch CE 1995 Presymptomatic DNA screening in families with multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma. Surgery 118:1099-1103; discussion 1103-1094
11. de Groot JW, Links TP, Plukker JT, Lips CJ, Hofstra RM 2006 RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors. Endocr Rev 27:535-560 (Pubitemid 44213230)
12. Da Silva AM, Maciel RM, Da Silva MR, Toledo SR, De Carvalho MB, Cerutti JM 2003 A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma. J Clin Endocrinol Metab 88:5438-5443 (Pubitemid 37452751)
13. Muzza M, Cordella D, Bombled J, Bressac-de Paillerets B, Guizzardi F, Francis Z, Beck-Peccoz P, Schlumberger M, Persani L, Fugazzola L 2010 Four novel RET germline variants in exons 8 and 11 display an oncogenic potential in vitro. Eur J Endocrinol 162:771-777
14. Motte P, Vauzelle P, Gardet P, Ghillani P, Caillou B, Parmentier C, Bohuon C, Bellet D 1988 Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies. Clin Chim Acta 174:35-54
15. Guilloteau D, Perdrisot R, Calmettes C, Baulieu JL, Lecomte P, Kaphan G, Milhaud G, Besnard JC, Jallet P, Bigorgne JC 1990 Diagnosis of medullary carcinoma of the thyroid (MCT) by calcitonin assay using monoclonal antibodies: criteria for the pentagastrin stimulation test in hereditary MCT. J Clin Endocrinol Metab 71:1064-1067
16. Frank-Raue K, Buhr H, Dralle H, Klar E, Senninger N, Weber T, Rondot S, Hoppner W, Raue F 2006 Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophy-lactic thyroidectomy: impact of individual RET genotype. Eur J Endocrinol 155:229-236 (Pubitemid 44269439)
17. Scheuba C, Bieglmayer C, Asari R, Kaczirek K, Izay B, Kaserer K, Niederle B 2007 The value of intraoperative pentagastrin testing in medullary thyroid cancer. Surgery 141:166-171; discussion 171-162
18. d'Herbomez M, Caron P, Bauters C, Cao CD, Schlienger JL, Sapin R, Baldet L, Carnaille B, Wemeau JL 2007 Reference range of serum calcitonin levels in humans: influence of calcitonin assays, sex, age, and cigarette smoking. Eur J Endocrinol 157:749-755
19. Barbot N, Calmettes C, Schuffenecker I, Saint-Andre JP, Franc B, Rohmer V, Jallet P, Bigorgne JC 1994 Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma. J Clin Endocrinol Metab 78:114-120
20. Wion-Barbot N, Schuffenecker I, Niccoli P, Conte-Devolx B, Lecomte P, Houdent C, Bigorgne JC, Modigliani E 1997 Results of the calcitonin stimulation test in normal volunteers compared with genetically unaffected members of MEN 2A and familial medullary thyroid carcinoma families. Ann Endocrinol (Paris) 58:302-308 (Pubitemid 27445116)
21. Guyetant S, Josselin N, Savagner F, Rohmer V, Michalak S, Saint-Andre JP 2003 C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients. Mod Pathol 16:756-763 (Pubitemid 37011070)
22. Guyetant S, Wion-Barbot N, Rousselet MC, Franc B, Bigorgne JC, Saint-Andre JP 1994 C-cell hyperplasia associated with chronic lymphocytic thyroiditis: a retrospective quantitative study of 112 cases. Hum Pathol 25:514-521 (Pubitemid 24173869)
23. Guyetant S, Rousselet MC, Durigon M, Chappard D, Franc B, Guerin O, Saint-Andre JP 1997 Sex-related C cell hyperplasia in the normal human thyroid: a quantitative autopsy study. J Clin Endocrinol Metab 82:42-47 (Pubitemid 27021268)
24. Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven TJ, Roeher HD, Wahl RA, Lamesch P, Raue F, Conte-Devolx B, Dralle H 2003 Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349:1517-1525 (Pubitemid 37255037)
25. Bugalho MJ, Domingues R, Santos JR, Catarino AL, Sobrinho L 2007 Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre. Surgery 141:90-95 (Pubitemid 44918073)
26. Skinner MA, Moley JA, Dilley WG, Owzar K, Debenedetti MK, Wells Jr SA 2005 Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 353:1105-1113 (Pubitemid 41317433)
27. Szinnai G, Meier C, Komminoth P, Zumsteg UW 2003 Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis. Pediatrics 111:E132-E139
28. Leboulleux S, Travagli JP, Caillou B, Laplanche A, Bidart JM, Schlumberger M, Baudin E 2002 Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course. Cancer 94:44-50 (Pubitemid 34049041)
29. Telander RL, Zimmerman D, Sizemore GW, van Heerden JA, Grant CS 1989 Medullary carcinoma in children. Results of early detection and surgery. Arch Surg 124:841-843
30. Cohen R, Campos JM, Salaun C, Heshmati HM, Kraimps JL, Proye C, Sarfati E, Henry JF, Niccoli-Sire P, Modigliani E 2000 Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma. Groupe d'Etudes des Tumeurs a Calcitonine (GETC). J Clin Endocrinol Metab 85:919-922 (Pubitemid 32273687)
31. Machens A, Schneyer U, Holzhausen HJ, Dralle H 2005 Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level. J Clin Endocrinol Metab 90:2029-2034 (Pubitemid 40586235)
32. Machens A, Dralle H 2010 Biomarker-based risk stratification for previously untreated medullary thyroid cancer. J Clin Endocrinol Metab 95:2655-2663